BGM Group

BGMNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$120.347 M

$0.30 +1.45%

Close of 7 Aug 2026

Revenue

$37.9M

#2830 by revenue

Earnings

-$19.9M

Loss-making

Shares outstanding

200,623,358

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#296Spruce BiosciencesSPRB$129.0M
#297Tiziana Life SciencesTLSA$127.3M
#298BGM GroupBGM$120.3M
#299GeneluxGNLX$119.3M
#300Cumberland PharmaceuticalsCPIX$116.9M

Where these numbers come from

Share counts and financials for BGM Group are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.